Analysis of roles of tumor suppressor gene WT1 in human leukemogenesis.
抑癌基因WT1在人类白血病发生中的作用分析。
基本信息
- 批准号:09470230
- 负责人:
- 金额:$ 7.81万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Wilms' tumor gene WT1 was identified as a gene responsible for Wilms' tumor, a childhood kidney neoplasm and classified as a tumor suppressor gene. The WT1 gene encoding a zinc finger transcription factor represses transcription of growth factors, p growth factor receptors and some other genes. We have reported high levels of wild-type WT1 expression in fresh leukemic cells regardless of the types of leukemias. Furthermore, WT1 antisense oligomer specifically inhibited the growth of leukemia cells. These results have raised a hypothesis that the wild-type WT1 gene exerts an oncogenic rather than a tumor suppressor gene function in hematopoietic progenitor cells and plays an important role in leukemogenesis. To prove this hypothesis, a series of experiments were performed. 32D c13, an interleukin 3-dependent myeloid progenitor cell line, differentiates into mature neutrophils in response to G-CSF.However, when transfected wild-type WT1 gene was constitutively expressed in 32D c13 cells, the cells stopped differentiating and continued to proliferate in response to G-CSF.Furthermore, significantly more CFU-GM, CFU-G, and CFU-M colonies were formed in WP1-infected bone marrow (BM) cells than in control BM cells in response to G-CSF.These results supported our hypothesis.
肾母细胞瘤基因WT 1被鉴定为负责肾母细胞瘤(一种儿童肾脏肿瘤)的基因,并被归类为肿瘤抑制基因。编码锌指转录因子的WT 1基因抑制生长因子、β生长因子受体和其他一些基因的转录。我们已经报道了高水平的野生型WT 1表达在新鲜的白血病细胞,无论类型的白血病。WT 1反义寡聚体能特异性抑制白血病细胞的生长。这些结果提出了一个假设,野生型WT 1基因发挥致癌,而不是肿瘤抑制基因的造血祖细胞的功能,并在白血病的发生中起着重要作用。为了证明这一假设,进行了一系列实验。32 D c13是一种白细胞介素3依赖的髓系祖细胞系,在G-CSF的刺激下可分化为成熟的中性粒细胞,而野生型WT 1基因转染后,32 D c13细胞在G-CSF的刺激下可停止分化并继续增殖,同时,32 D c13细胞的CFU-GM、CFU-G、在G-CSF刺激下,WP 1感染的骨髓细胞比对照骨髓细胞形成CFU-M集落,这些结果支持了我们的假设。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inoue K.et al.: "Wilms'tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells." Blood. 91. 2969-2976 (1998)
Inoue K.等人:“维尔姆斯肿瘤基因(WT1)与造血祖细胞中的分化诱导信号竞争。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Inoue K.: "Aberrant overexpression of the Wilms tumor gene(WT1)in human leukemia." Blood. 89. 1405-1412 (1997)
Inoue K.:“人类白血病中维尔姆斯肿瘤基因(WT1)的异常过度表达。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sugiyama H.et al.: "Wilms tumor gene (WT1) mRNA is equally expressed in blast cells from acute myeloid leukemia and normal CD34+ progenitors (Response)." Blood. 90. 4230-4232 (1997)
Sugiyama H.等人:“Wilms 肿瘤基因 (WT1) mRNA 在急性髓性白血病和正常 CD34 祖细胞的母细胞中表达相同(响应)。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Inoue K.et al.: "Wilms'tumor gene(WT1)competes with differentiation-inducing signal in hematopoietic progenitor cells." Blood. 91. 2969-2976 (1998)
Inoue K.等人:“维尔姆斯肿瘤基因(WT1)与造血祖细胞中的分化诱导信号竞争。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tsuboi, A., Oka, Y., Ogawa, H., Elisseeva, A.A., Tamaki, H., Oji, Y., Kim, E.H., Soma, T., Tatekawa, T., Kawakami, M., Kishimoto, T., and Sugiyama, H.: "Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenito
坪井,A.,冈,Y.,小川,H.,Elisseeva,A.A.,玉木,H.,王子,Y.,金,E.H.,相马,T.,立川,T.,川上,M.,岸本,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUGIYAMA Haruo其他文献
SUGIYAMA Haruo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUGIYAMA Haruo', 18)}}的其他基金
Development of molecular diagnosis and molecule-targeted therapy for leukemia
白血病分子诊断和分子靶向治疗的进展
- 批准号:
17015028 - 财政年份:2005
- 资助金额:
$ 7.81万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
WT1 protein-targeted immunotherapy for leulemia
WT1蛋白靶向白血病免疫治疗
- 批准号:
15109007 - 财政年份:2003
- 资助金额:
$ 7.81万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Role of the Wilms' tumor gene WT1 in human leukemogenesis
维尔姆斯氏肿瘤基因 WT1 在人类白血病发生中的作用
- 批准号:
13470205 - 财政年份:2001
- 资助金额:
$ 7.81万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The role of the tumor suppressor gene WT1 in human leukemogenesis.
肿瘤抑制基因 WT1 在人类白血病发生中的作用。
- 批准号:
11470210 - 财政年份:1999
- 资助金额:
$ 7.81万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Role of the tumor suppressor gene WT1 in human leukemogenesis.
肿瘤抑制基因 WT1 在人类白血病发生中的作用。
- 批准号:
08457278 - 财政年份:1996
- 资助金额:
$ 7.81万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of the mechanisms of V_H gene selection in theformation of immunoglovulin heavy chain variable region genes.
V_H基因选择在免疫球蛋白重链可变区基因形成中的机制分析
- 批准号:
62570212 - 财政年份:1987
- 资助金额:
$ 7.81万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
ONCOGENE DEREGULATION/TUMOR SUPPRESSOR GENE LOSS IN CLL
CLL 中癌基因失调/抑癌基因丢失
- 批准号:
6513308 - 财政年份:1999
- 资助金额:
$ 7.81万 - 项目类别:
The role of the tumor suppressor gene WT1 in human leukemogenesis.
肿瘤抑制基因 WT1 在人类白血病发生中的作用。
- 批准号:
11470210 - 财政年份:1999
- 资助金额:
$ 7.81万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
ONCOGENE DEREGULATION/TUMOR SUPPRESSOR GENE LOSS IN CLL
CLL 中癌基因失调/抑癌基因丢失
- 批准号:
6376574 - 财政年份:1999
- 资助金额:
$ 7.81万 - 项目类别:
ONCOGENE DEREGULATION/TUMOR SUPPRESSOR GENE LOSS IN CLL
CLL 中癌基因失调/抑癌基因丢失
- 批准号:
2893734 - 财政年份:1999
- 资助金额:
$ 7.81万 - 项目类别:
ONCOGENE DEREGULATION/TUMOR SUPPRESSOR GENE LOSS IN CLL
CLL 中癌基因失调/抑癌基因丢失
- 批准号:
6172746 - 财政年份:1999
- 资助金额:
$ 7.81万 - 项目类别:
ONCOGENE DEREGULATION/TUMOR SUPPRESSOR GENE LOSS IN CLL
CLL 中癌基因失调/抑癌基因丢失
- 批准号:
6633289 - 财政年份:1999
- 资助金额:
$ 7.81万 - 项目类别:
Gene therapy for lung cancer using tumor suppressor gene product as molecular target
以抑癌基因产物为分子靶点的肺癌基因治疗
- 批准号:
09670615 - 财政年份:1997
- 资助金额:
$ 7.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immunohistochemical observation for oncogene and tumor suppressor gene products and extracellural materials in tumors in oral cavity.
口腔肿瘤癌基因、抑癌基因产物及细胞外物质的免疫组织化学观察。
- 批准号:
07457499 - 财政年份:1995
- 资助金额:
$ 7.81万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Tumor heterogeneity and alterations in oncogene and tumor suppressor gene in human prostate carcinoma
人前列腺癌肿瘤异质性及癌基因和抑癌基因的改变
- 批准号:
06670200 - 财政年份:1994
- 资助金额:
$ 7.81万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Analysis of p53 tumor suppressor gene and MDM2 gene in solid tumors in childhood.
儿童实体瘤p53抑癌基因和MDM2基因分析
- 批准号:
05671495 - 财政年份:1993
- 资助金额:
$ 7.81万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)